showed in subjects 1 and 3 minimal abnormality of bronchial reactivity and of ventilation distribution. Review of the literature reveals only two reports of asthma resulting from papain inhalation, although its antigenic and skin sensitizing qualities have been known and described for many years. It seems remarkable that a substance such as papain, shown to be a potent cause of lung damage in experimental animals, should have produced so little evidence of abnormality in our subjects after considerable exposure. Follow-up ventilatory function tests may cast further light on this but we postulate that the asthmatic response may be biologically protective and those lacking this reaction could later develop emphysema as a long-term outcome.
Technological advances and increasing affluence have facilitated the gradual mechanization of household tasks on a widening scale throughout the community. Concurrently, chemical and biochemical ingenuity has provided new and different methods of cleaning for the housewife. Among the latest products for use in home washing machines are detergents employing proteolytic enzymes. Gandevia (1970) remarked on the asthmatic manifestations that can occur after occupational inhalation of these bacterial proteolytic enzyme extracts as powder and as dust.
Another proteolytic enzyme widely used in a different milieu, by both research and industrial biochemists, is papain. Inhalation of this enzyme is an established cause of emphysema in experimental animals (Gross et al., 1965) . Considerable interest was aroused, therefore, when it became known that, in the course of an industrial research project, inhalation of papain had caused an acute episode of breathlessness and wheezing in two people.
Review of the literature Papain is a sulphydryl protease in a single polypeptide chain of molecular weight 23 000. The chain was shown by Drenth et al. (1968) , using a three dimensional x-ray study, to be folded into two distinct parts divided by a cleft. They stated that the active enzymatic site lies at the surface of the cleft. Arnon and Shapira (1967) used selective fractionation of rabbit antiserum to study antibodies to papain and compared various antibody preparations on the basis that these could inhibit the enzymatic activity of papain and their relative reactivity in the precipitin reaction. It was shown that the rabbit antibody spectrum is heterogeneous, that is, some antibodies inhibited enzymatic activity whereas others, although precipitating well with the enzyme, did not inhibit proteolytic activity.
Reports of pulmonary effects in humans are rare. Beecher (1951) However, apart from its bronchospasmodic effect in humans, there is experimental evidence that papain has also caused pulmonary emphysema in animals (Gross et al., 1964) .
Experiments were carried out on normal and silicotic rats (Gross et al., 1965) , and later an 'interspecies gradation in the severity of the emphysema' was shown (Gross et al., 1968) . Guinea-pigs and rats both developed emphysema after the intratracheal instillation of papain, and it should be noted that in each animal species, a single intratracheal instillation of approximately 1 mg papain was sufficient to produce emphysematous change of a pattern exactly similar to that commonly found in humans.
Goldrinlg, Greenburg, and Ratner (1968) employed a modification of the method of Gross, using Syrian hamsters. Instead of instilling papain directly into the trachea of the experimental animal, they sought complete involvement of all lung lobes by using the papain as an aerosol of particle size less than 5 ,um, small enough to reach the alveoli. They were able to produce emphysema in all lobes of the lungs of all 12 animals and they stated that 'The lesions are panacinar and similar to those seen in the human lung'. Since they used papain in aerosol form and the animals were exposed in a plastic exposure chamber, their experimental conditions were more comparable with our industrial situation than those of Gross et al. (1964 Gross et al. ( , 1965 Gross et al. ( , 1968 who employed intratracheal instillation. Goldring et al. (1968) also found that all their experimental animals had asthma. They noted that 'within 18 hours after exposure, all 12 of the treated animals exhibited signs of severe respiratory distress, laboured breathing, wheezing, rales, and increased salivation'. All papain-exposed animals recovered from the acute respiratory distress within a week and the exposure continued for at least another 50 days in all cases, and up to 120 days in some.
Case reports Case 1 A 27-year-old female analytical chemist had suffered from occasional attacks of bronchitis and bronchial asthma fromthe age ofabout 7to 15 years. Shehadalwaysnoticeda tendency to wheeze on exertion or on laughing. There was a family history of hay fever. Her general health was good and she was free of asthma until the day in question when, while working in the laboratory, she noticed a 'fine dusty smoke-like effect' in the corridor. Unknown to her at that time, this was papain dust from a sifting process as part of a research project being carried out for the first time in a nearby room. Over the next 10 to 15 minutes she noticed eye irritation followed by increasing nasal secretion, and then the rapid, almost abrupt onset of asthma which within a further 10 minutes had become so distressing that her chest ached from the effort of breathing and she wheezed heavily. She had to cease work and was taken by ambulance to a nearby hospital where she was given treatment which included an injection of adrenaline. About 14 hours later her symptoms had considerably abated and she was allowed to go home. Some days later she consulted one of us (SB) and was asked to bring some papain to make a preparation for the testing of skin sensitivity. In the subsequent handling of the small amount of papain that was necessary she was not exposed to a visible powder but she experienced an itchy irritation of the eyes and a running nose which lasted three days. Skin tests were carried out using a scratch method. The crude papain granules had been milled to a fine powder for the factory process and a sample of this powder, as used by the operatives, was obtained. Coca's solution was used as a diluent, and to 0-02 ml of this solution was added sufficient papain powder to make a smooth paste. A scratch (3-5 mm in length) was made on the woman's arm without drawing blood so as to expose the superficial layers of epidermis. The paste was applied gently to the scratched area and a control test using diluent alone was concurrently performed. The area was continuously observed over a period of 10 minutes and an unequivocally positive reaction appeared rapidly. This consisted of an urticarial weal approximately 9 mm in diameter, an actively developing pseudopodia about 20 mm in length, and erythema about 60 mm in diameter. The control test was negative.
Using the same technique, skin tests were performed on the patient to assess sensitivity to common grass pollens, animal hair, and house dust. All these were negative.
Skin tests were also performed in the same way on another 100 consecutive subjects to assess their sensitivity to the papain powder, and none showed a positive reaction.
No wheeze occurred when this patient handled the sample of powder, or at the time of the skin test, but that night she experienced an attack of asthma. A few days later when she returned to work in the laboratory, she noticed wheezing and sometimes breathlessness on effort. This gradually disappeared over the succeeding 12 months except for about three months after the acute episode when she was away from the laboratory for a period of several weeks and lost all respiratory symptoms. When she returned to work she again became aware of exertional wheeze. After the gradual abatement of symptoms, her general health returned to what she describes as its normal state.
The firm had discontinued the use of papain in the area in which she worked by the time she returned to the laboratory. Apart from residual dust from the original episode, she was subjected to no further occupational source of papain exposure and she has never used papain in her job since.
Case 2
A 32-year-old male industrial research chemist had no personal history of allergy, asthma, or hay fever but there was a family history ofhay fever. He usually worked in the same factory as the analytical chemist, but in a different building. He was involved in a research project concerning the use of papain for proteolysis in a proprietary food mix. The project required the grinding of relatively large lumps of papain and then sifting it.
On the day in question he was working in the same room as the grinding machine. The room was about 6 x 7 x 3 m and he worked about 2 to 3 m from the grinder. About five minutes after the grinding began he began to sneeze. About 10 minutes later he started to cough and soon after he noticed that he was wheezing. He was not conscious of seeing or smelling anything in the air. His chest condition proved too much for him to remain where he was, so he went to another building and over the next three hours his symptoms subsided until he was just aware of some slight residual irritation in his chest but had no real discomfort.
Unknown to him, however, sifting was to be carried out in this second building. That day the powder arrived and when sifting started, as previously described in case 1, a fine dust like a smoke appeared in the corridor. Although this was on the floor below the one on which he was now working, the cough returned soon after and was followed by a marked wheeze. He was breathless and distressed and was taken to the same nearby hospital, where his symptoms abated after treatment.
Skin tests (scratch method) were carried out in the same way as described for case 1. These were negative to common grass pollens, animal hair, and house dust; but the papain test was unequivocally positive producing an urticarial weal of similar dimensions to that described in the previous patient, and that night he experienced an attack of asthma.
In the succeeding two months he noticed that any exertion that was sufficient to make him breathless also made him wheeze. He then went on holiday and although he spent about three weeks in quite severe exertion he did not wheeze during this period. On his return to work the wheeze was noted to be present again during exertional dyspnoea, but it slowly abated and finally disappeared about a year after the original attack. The industrial process was discontinued after this patient's acute episode of asthma dyspnoea and he was no longer exposed to papain, apart from the possibility of residual dust in his working area.
Asthma occurred in the two cases described above. Of others similarly exposed, two who did not wheeze were later assessed by lung function studies at the same time as the two asthmatics. Their case histories are briefly detailed.
Although it was clearly recognized that these were not matched controls, nevertheless they were the only controls available; hence it was considered worthwhile to assess their pulmonary function because this represented the only method available to investigate the differences in pulmonary physiology between the two patients with an asthmatic-type reaction and two other subjects who had been similarly exposed but did not exhibit symptoms.
Case 3 A 39-year-old man was in charge of the hammer mill in which the crude papain was ground from about popcorn size to fine powder. He had handled crude papain before, and on this occasion was exposed without respiratory protection for about Ij hours twice weekly for three weeks to papain dust in the air, described as a fine cloud around the mill.
He noticed a running nose at first but this soon dis- Respiratory function Assessment of respiratory function was performed 17 months after exposure. Ventilatory capacity was measured using standard spirometric techniques. (Needham, Rogan, and McDonald, 1954 Non-specific bronchial reactivity was assessed using methacholine aerosol challenge by techniques previously described (Cade and Pain, 1971) . A multibreath nitrogen washout test with the subject breathing oxygen was used to assess ventilation maldistribution (Fowler, Cornish, and Kety, 1952) . Linearity in the plot of log expired nitrogen concentration against time was taken as evidence of normal ventilation distribution. The physiological dead space/tidal volume ratio (VD/VT), an index of ventilation/blood flow relationships, was calculated from simultaneous measurements of carbon dioxide tension in the expired air (Godart Pulmoanalyser) and arterial blood (Severinghaus Pco2 electrode) during a two minute collection period with the subjects semirecumbent. The dead space was corrected for apparatus dead space. Diffusing capacity of the lungs for carbon monoxide (TLCO) was assessed by the steady-state technique of Holland and Blacket (1958) . The ventilatory capacity was within normal limits in all subjects (see Table) . Methacholine challenge revealed an abnormally large reduction in ventilatory capacity in subjects 1 and 3, indicating heightened bronchial reactivity. These two people also had evidence of maldistribution of ventilation before methacholine challenge. In no subject was the VD/VT ratio significantly raised. In subject 1, the diffusing capacity was at the lowerlimit ofnormal.
Thus, at that stage, thetwo subjects who developed asthma were functionally similar to the two asymptomatically exposed subjects. The subject who had a history of asthma (subject 1) showed features commonly found in interval asthmatics (Cade and Pain, 1973) . It is of interest that subject 2 appeared not to have retained heightened bronchial reactivity, assuming he had an abnormal bronchial responsiveness at the time of clinical symptoms, a feature mentioned by Mitchell (1970) Flindt (1969) is a paper by Pepys et al. (1969) who employed bronchial challenge by experimental inhalation of the B. subtilis enzyme in three workers and found that asthmatic reactions resulted.
It seems reasonable to assume that, after the original heavy exposure, the working conditions described in our cases of occupational asthma were such as to cause small gradually diminishing amounts of residual papain dust to become recurrently airborne. The persistence and slow subsidence of symptoms over a period of many months in each case could then be presumed to be caused by recurrent bronchial challenge from the industrial environment.
We felt it inadvisable to attempt deliberately to reproduce the bronchospasm by bronchial challenge in a respiratory physiology unit, bearing in mind the profound original asthmatic attacks, the marked skin sensitivity, and the nocturnal exacerbations after skin testing.
A relationship with the possible development of emphysema must be considered in those inhaling proteolytic enzymes, especially papain, because of the finding of Gross et al. (1965) who reported emphysema within six hours of one instillation intratracheally into guinea-pigs. Gandevia and Mitchell (1971) drew attention to this possibility and in a study of 36 men they found evidence of loss of elastic recoil in the lungs of a highly exposed group. They go on to say that they 'conclude that the observed loss of elastic recoil is attributable to occupational exposure to proteolytic enzymes, and ... believe it is likely to be permanent. In the absence of severe longstanding and chronic airways obstruction, . . . the only known and generally accepted cause of loss of elastic recoil is emphysema'.
In the light of the foregoing, and on the evidence provided by our four subjects, one may speculate as to whether the inhalation of papain might have produced emphysematous changes. The answer at this juncture cannot be other than conjectural. It is our intention with the co-operation of the industry, to conduct long-term follow-up studies. Our present results indicate some minimal abnormality in nitrogen washout, pointing to some change in the small airways, but we cannot relate this specifically to papain inhalation.
It seems unlikely that these changes in nitrogen washout are related to inhalation of papain since they are minimal and differ in case incidence from the cases of acute asthma. It is remarkable that there is so little evidence of abnormality resulting from severe exposure to a substance that has been shown to have a potent effect on animal lungs.
Experiments with animals by Gross et al. (1968) showed that guinea-pigs 'apparently become sensitized after the first instillation.. . Some died with findings characteristic of anaphylactic shock when a second dose was injected'. The first dose produced emphysema in all animals, which may indicate that the first effect of the enzyme on the lungs of the animal is proteolytic and that this also provides primary sensitization so that a second instillation may cause anaphylaxis.
If we assume that it is the proteolytic effect of papain which produces emphysema by tissue destruction, the presence of proteolysis-inhibiting antibodies would then appear to prevent the occurrence of emphysema.
From the work of Arnon and Shapira (1967) one may conclude that at least some rabbit antibodies will inhibit proteolysis. It would seem probable that a similar antibody spectrum exists in human serum. Hence an antigen-antibody reaction to papain in humans, although producing asthma, could also imply less chance of emphysema occurring in the immune individual. Goldring et al. (1968) would appear to contradict this hypothesis but the exposure time in their study was prolonged. Further studies including long-term follow-ups may provide the answer, and could be of significance in view of the widespread use of papain and other proteolytic enzymes, for example, bromelains, trypsin, etc., among biochemists and food technologists, who constantly come into contact with these enzymes in the course of their work.
